Straits Times Index
3,303.66 +12.96 (+0.39%) S&P 500
5,218.00 -4.68 (-0.09%) Dow
39,429.69 -83.15 (-0.21%) Nasdaq
16,374.92 +34.06 (+0.21%) Bitcoin USD
62,740.38 +1,120.16 (+1.82%) CMC Crypto 200
1,292.58 +32.37 (+2.57%)
Esperion Therapeutics, Inc. (0ET.F)
| Previous close | 1.7650 |
| Open | 1.8320 |
| Bid | 0.0000 x N/A |
| Ask | 0.0000 x N/A |
| Day's range | 1.8320 - 1.8320 |
| 52-week range | 0.6660 - 2.9880 |
| Volume | |
| Avg. volume | 113 |
| Market cap | 399.506M |
| Beta (5Y monthly) | 0.82 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.8900 |
| Earnings date | 30 Jul 2024 - 05 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 42.45 |
GlobeNewswireEsperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
ANN ARBOR, Mich., May 10, 2024 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that on May 8, 2024, the Company granted 16 new employees 62,300 restricted stock units (RSUs) under Esperion’s 2017 Inducement Equity Incentive Plan. The 2017 Inducement Equity Incentive Plan is used exclusively for the grant of equity awards to individuals who were not previously an employee or non-employee director of Esperion (or following a bona fide period of non-employment), as an inducement materia
ZacksEsperion (ESPR) Q1 Earnings Beat, Stock Up on Strong Revenues
Esperion's (ESPR) first-quarter earnings and sales beat estimates on the back of better-than-expected collaboration revenues.
Insider MonkeyEsperion Therapeutics, Inc. (NASDAQ:ESPR) Q1 2024 Earnings Call Transcript
Esperion Therapeutics, Inc. (NASDAQ:ESPR) Q1 2024 Earnings Call Transcript May 7, 2024 Esperion Therapeutics, Inc. beats earnings expectations. Reported EPS is $0.00032, expectations were $-0.17. ESPR isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Ladies and gentlemen, thank you for […]
